SALARIUS PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01 Other Events.

On January 19, 2021, Salarius Pharmaceuticals, Inc. (the "Company") received
notice from Listing Qualifications Department (the "Staff") of the Nasdaq Stock
Market confirming that the Staff has determined that for the last 10 consecutive
business days, from January 4 to January 15, 2021, the closing bid price of the
Company's common stock has been at $1.00 per share or greater. Accordingly, the
Staff has determined that the Company has regained compliance with Nasdaq
Listing Rule 5550(a)(2) and it has indicated to the Company that this matter is
now closed.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.
Exhibit Number                                               Description
                             Press Release Announcing     Salarius     Pharmaceuticals     Regain    s
                             Compliance with Nasdaq Minimum Bid Price Listing Requirement, dated January
99.1                       21, 2021

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses